Section 1927 of the Social Security
Act requires drug manufacturers to enter into and have in effect a
rebate agreement with CMS in order for States to receive funding
for drugs dispensed to Medicaid recipients. Drug manufacturers must
explain to States any rebate payment adjustments for the current
quarter, and any prior quarters. The information is used to
reconcile drug rebate payments made by manufacturers with the State
invoices of rebates due.
For PQAS, the number of
labelers has been adjusted from 595 to 610 due to the increase in
labeler participation. Similarly, the number of labelers for ROSI
has been adjusted to 427 or 70 percent of 610. While the time per
response remains unchanged, the total hours and cost have been
adjusted to reflect the revised number of labelers.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.